The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Open accessAbstract
Despite efficient combination of the antiretroviral therapy (cART), which significantly decreased mortality and morbidity of HIV-1 infection, a definitive HIV cure has not been achieved. Hidden HIV-1 in cellular and anatomic reservoirs is the major hurdle toward a functional cure. Microglial cells, the Central Nervous system (CNS) resident macrophages, are one of the major cellular reservoirs of latent HIV-1. These cells are believed to be involved in the emergence of drugs resistance and reseeding peripheral tissues. Moreover, these long-life reservoirs are also involved in the development of HIV-1-associated neurocognitive diseases (HAND). Clearing these infected cells from the brain is therefore crucial to achieve a cure. However, many characteristics of microglial cells and the CNS hinder the eradication of these brain reservoirs. Better understandings of the specific molecular mechanisms of HIV-1 latency in microglial cells should help to design new molecules and new strategies preventing HAND and achieving HIV cure. Moreover, new strategies are needed to circumvent the limitations associated to anatomical sanctuaries with barriers such as the blood brain barrier (BBB) that reduce the access of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Koenig, S., Gendelman, H. E., Orenstein, J. M., Dal Canto, M. C., Pezeshkpour, G. H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M. A., & Fauci, A. S. (1986) · Science · doi:10.1126/science.3016903 · Cited by 1,698
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,457
Davey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes
Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G., & Zhang, H. (2007) · Nature Medicine · doi:10.1038/nm1639 · Cited by 768
Turnover of resident microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., & Gordon, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90500-2 · Cited by 709
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., & Schneider, T. (2011) · Blood · doi:10.1182/blood-2010-09-309591 · Cited by 681
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
Whitney, J. B., Hill, A. L., Sanisetty, S., Penaloza-MacMaster, P., Liu, J., Shetty, M., Parenteau, L., Cabral, C., Shields, J., Blackmore, S., et al. (2014) · Nature · doi:10.1038/nature13594 · Cited by 629
The Challenge of Viral Reservoirs in HIV-1 Infection
Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 627
A Multifunctional AAV-CRISPR-Cas9 and Its Host Response
Chew, W. L., Tabebordbar, M., Cheng, J. K. W., Mali, P., Wu, E. Y., Ng, A. H. M., Zhu, K., Wagers, A. J., & Church, G. M. (2016) · Nature Methods · doi:10.1038/nmeth.3993 · Cited by 617
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Gupta, R. K., Abdul-Jawad, S., McCoy, L. E., Mok, H. P., Peppa, D., Salgado, M., Martinez-Picado, J., Nijhuis, M., Wensing, A. M. J., Lee, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1027-4 · Cited by 595
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565 · cited 3×
“The first targeted DNA sequence by the CRISPR/Cas9 technology was the NFKB binding site located in the HIV-1 LTR (Ebina et al., 2013).”
BackgroundThe Lifespan and Turnover of Microglia in the Human Brain
Réu, P., Khosravi, A., Bernard, S., Mold, J. E., Salehpour, M., Alkass, K., Perl, S., Tisdale, J., Possnert, G., Druid, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.004 · Cited by 515
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H. L., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 504
Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells
Sheng, J., Ruedl, C., & Karjalainen, K. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.016 · Cited by 489
Taniguchi, T., & Takaoka, A. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00305-3 · Cited by 482
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474
Jordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
Dornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 463
Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 414
Canestri, A., Lescure, F., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G., & Katlama, C. (2010) · Clinical Infectious Diseases · doi:10.1086/650538 · Cited by 405
Chun, T.-W., Davey, R. T., Ostrowski, M., Shawn Justement, J., Engel, D., Mullins, J. I., & Fauci, A. S. (2000) · Nature Medicine · doi:10.1038/77481 · Cited by 404
Phosphorylation of SAMHD1 by Cyclin A2/CDK1 Regulates Its Restriction Activity toward HIV-1
Cribier, A., Descours, B., Valadão, A. L. C., Laguette, N., & Benkirane, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.017 · Cited by 370
Cytokines, chemokines, and cytokine receptors in human microglia
Lee, Y. B., Nagai, A., & Kim, S. U. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10253 · Cited by 363
Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications
Hong, S., & Banks, W. A. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.008 · Cited by 360
Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., & Giffard, R. G. (2006) · Stroke · doi:10.1161/01.str.0000206281.77178.ac · Cited by 359
Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing
Marban, C., Suzanne, S., Dequiedt, F., de Walque, S., Redel, L., Van Lint, C., Aunis, D., & Rohr, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601516 · Cited by 354
Self-citationTargeting the Latent Reservoir for HIV-1
Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 340
Extensive astrocyte infection is prominent in human immunodeficiency virus–associated dementia
Churchill, M. J., Wesselingh, S. L., Cowley, D., Pardo, C. A., McArthur, J. C., Brew, B. J., & Gorry, P. R. (2009) · Annals of Neurology · doi:10.1002/ana.21697 · Cited by 339
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
For the German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI), Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8503-2 · Cited by 339
HIV-infected T cells are migratory vehicles for viral dissemination
Murooka, T. T., Deruaz, M., Marangoni, F., Vrbanac, V. D., Seung, E., von Andrian, U. H., Tager, A. M., Luster, A. D., & Mempel, T. R. (2012) · Nature · doi:10.1038/nature11398 · Cited by 322
Li, Z., Guo, J., Wu, Y., & Zhou, Q. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks976 · Cited by 301
HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
Edén, A., Fuchs, D., Hagberg, L., Nilsson, S., Spudich, S., Svennerholm, B., Price, R. W., & Gisslén, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657342 · Cited by 286
Darcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005063 · Cited by 281
Self-citationHIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
Honeycutt, J. B., Thayer, W. O., Baker, C. E., Ribeiro, R. M., Lada, S. M., Cao, Y., Cleary, R. A., Hudgens, M. G., Richman, D. D., & Garcia, J. V. (2017) · Nature Medicine · doi:10.1038/nm.4319 · Cited by 281
Janabi, N., Peudenier, S., Héron, B., Ng, K. H., & Tardieu, M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11792-h · Cited by 280
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
Koppensteiner, H., Brack-Werner, R., & Schindler, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-82 · Cited by 280
García, F., Plana, M., Vidal, C., Cruceta, A., O‚Brien, W. A., Pantaleo, G., Pumarola, T., Gallart, T., Miró, J. M., & Gatell, J. M. (1999) · AIDS · doi:10.1097/00002030-199907300-00002 · Cited by 271
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Bruel, T., Guivel-Benhassine, F., Amraoui, S., Malbec, M., Richard, L., Bourdic, K., Donahue, D. A., Lorin, V., Casartelli, N., Noël, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10844 · Cited by 271
The human microglial HMC3 cell line: where do we stand? A systematic literature review
Dello Russo, C., Cappoli, N., Coletta, I., Mezzogori, D., Paciello, F., Pozzoli, G., Navarra, P., & Battaglia, A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1288-0 · Cited by 265
Kaushik, A., Yndart, A., Atluri, V., Tiwari, S., Tomitaka, A., Gupta, P., Jayant, R. D., Alvarez-Carbonell, D., Khalili, K., & Nair, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-40222-4 · Cited by 254
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Descours, B., Petitjean, G., López-Zaragoza, J.-L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. (2017) · Nature · doi:10.1038/nature21710 · Cited by 242
Cosenza;, M. A., Zhao;, M., Si;, Q., & Lee, S. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00461.x · Cited by 238
Microglia function during brain development: New insights from animal models
Bilimoria, P. M., & Stevens, B. (2015) · Brain Research · doi:10.1016/j.brainres.2014.11.032 · Cited by 237
Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y.-J., Metzger, D. S., & Ho, W.-Z. (2009) · Blood · doi:10.1182/blood-2008-09-175000 · Cited by 236
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
Mousseau, G., Kessing, C. F., Fromentin, R., Trautmann, L., Chomont, N., & Valente, S. T. (2015) · mBio · doi:10.1128/mbio.00465-15 · Cited by 231
CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
Wang, Z., Pan, Q., Gendron, P., Zhu, W., Guo, F., Cen, S., Wainberg, M. A., & Liang, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.042 · Cited by 231
Churchill, M. J., Gorry, P. R., Cowley, D., Lal, L., Sonza, S., Purcell, D. F., Thompson, K. A., Gabuzda, D., McArthur, J. C., Pardo, C. A., et al. (2006) · Journal of Neurovirology · doi:10.1080/13550280600748946 · Cited by 221
The HIV Reservoir in Monocytes and Macrophages
Wong, M. E., Jaworowski, A., & Hearps, A. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01435 · Cited by 221
HIV-1 Latency in Monocytes/Macrophages
Kumar, A., Abbas, W., & Herbein, G. (2014) · Viruses · doi:10.3390/v6041837 · Cited by 217
Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2016) · Molecular Therapy · doi:10.1038/mt.2016.24 · Cited by 215
Avram, D., Fields, A., Top, K. P. O., Nevrivy, D. J., Ishmael, J. E., & Leid, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10315 · Cited by 213
Williams, D. W., Eugenin, E. A., Calderon, T. M., & Berman, J. W. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811394 · Cited by 212
Targets for human encoded microRNAs in HIV genes
Hariharan, M., Scaria, V., Pillai, B., & Brahmachari, S. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.183 · Cited by 211
Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
Thompson, K. A., Cherry, C. L., Bell, J. E., & McLean, C. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.039 · Cited by 210
Monocyte/macrophages and their role in HIV neuropathogenesis
Burdo, T. H., Lackner, A., & Williams, K. C. (2013) · Immunological Reviews · doi:10.1111/imr.12068 · Cited by 208
T-cell costimulation–biology, therapeutic potential, and challenges.
Sharpe, A. H., & Abbas, A. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068087 · Cited by 206
Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study
Kaminski, R., Bella, R., Yin, C., Otte, J., Ferrante, P., Gendelman, H. E., Li, H., Booze, R., Gordon, J., Hu, W., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.41 · Cited by 203
HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation.
Chivero, E. T., Guo, M.-L., Periyasamy, P., Liao, K., Callen, S. E., & Buch, S. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3045-16.2017 · Cited by 201
CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection
Yadav, A., & Collman, R. G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9174-2 · Cited by 199
Bartholomeeusen, K., Xiang, Y., Fujinaga, K., & Peterlin, B. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410746 · Cited by 197
Ko, A., Kang, G., Hattler, J. B., Galadima, H. I., Zhang, J., Li, Q., & Kim, W.-K. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9809-2 · Cited by 197
Gorry, P., Ong, C., Thorpe, J., Bannwarth, S., Thompson, K., Gatignol, A., Wesselingh, S., & Purcell, D. (2003) · Current HIV Research · doi:10.2174/1570162033485122 · Cited by 193
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
Le Douce, V., Herbein, G., Rohr, O., & Schwartz, C. (2010) · Retrovirology · doi:10.1186/1742-4690-7-32 · Cited by 192
Self-citationNeuroinflammation in treated HIV-positive individuals: A TSPO PET study
Vera, J. H., Guo, Q., Cole, J. H., Boasso, A., Greathead, L., Kelleher, P., Rabiner, E. A., Kalk, N., Bishop, C., Gunn, R. N., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002485 · Cited by 188
Garcia-Mesa, Y., Jay, T. R., Checkley, M. A., Luttge, B., Dobrowolski, C., Valadkhan, S., Landreth, G. E., Karn, J., & Alvarez-Carbonell, D. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-016-0499-3 · Cited by 188
Molecular and pathologic insights from latent HIV-1 infection in the human brain
Desplats, P., Dumaop, W., Smith, D., Adame, A., Everall, I., Letendre, S., Ellis, R., Cherner, M., Grant, I., & Masliah, E. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2e9e · Cited by 187
Joseph, S. B., Arrildt, K. T., Sturdevant, C. B., & Swanstrom, R. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-014-0287-x · Cited by 185
Karn, J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328340ffbb · Cited by 184
Sumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., Yamauchi, A., Dohgu, S., & Kataoka, Y. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9446-7 · Cited by 179
Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells
Baxter, A. E., Russell, R. A., Duncan, C. J. A., Moore, M. D., Willberg, C. B., Pablos, J. L., Finzi, A., Kaufmann, D. E., Ochsenbauer, C., Kappes, J. C., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.10.010 · Cited by 179
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Xiao, Q., Guo, D., & Chen, S. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00069 · Cited by 179
Novel Latency Reversal Agents for HIV-1 Cure
Spivak, A. M., & Planelles, V. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-052716-031710 · Cited by 174
Epigenetics Control Microglia Plasticity
Cheray, M., & Joseph, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00243 · Cited by 173
Nagai, A., Nakagawa, E., Hatori, K., Choi, H. B., McLarnon, J. G., Lee, M. A., & Kim, S. U. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0437 · Cited by 171
HIV “shock and kill” therapy: In need of revision
Abner, E., & Jordan, A. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.03.008 · Cited by 170
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jessen Krut, J., Mellberg, T., Price, R. W., Hagberg, L., Fuchs, D., Rosengren, L., Nilsson, S., Zetterberg, H., & Gisslén, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088591 · Cited by 167
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
Rohr, O., Marban, C., Aunis, D., & Schaeffer, E. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403180 · Cited by 166
Self-citationMicroglia: Key players in neurodevelopment and neuronal plasticity
Sominsky, L., Luca, S. N. D., & Spencer, S. J. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.11.012 · Cited by 163
Avalos, C. R., Abreu, C. M., Queen, S. E., Li, M., Price, S. L., Shirk, E. N., Engle, E. L., Forsyth, E. R., Bullock, B. T., Gabhann, F. M., et al. (2017) · mBio · doi:10.1128/mbio.01186-17 · Cited by 162
Rao, V. R., Ruiz, A. P., & Prasad, V. R. (2014) · AIDS Research and Therapy · doi:10.1186/1742-6405-11-13 · Cited by 161
Zhang, Y., Yin, C., Zhang, T., Li, F., Yang, W., Kaminski, R., Fagan, P. R., Putatunda, R., Young, W.-B., Khalili, K., et al. (2015) · Scientific Reports · doi:10.1038/srep16277 · Cited by 160
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection
Barmania, F., & Pepper, M. S. (2013) · Applied & Translational Genomics · doi:10.1016/j.atg.2013.05.004 · Cited by 159
Molecular mechanisms of HIV latency
Cary, D. C., Fujinaga, K., & Peterlin, B. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80565 · Cited by 158
Qu, D., Sun, W.-W., Li, L., Ma, L., Sun, L., Jin, X., Li, T., Hou, W., & Wang, J.-H. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz117 · Cited by 158
HIV Latency: Should We Shock or Lock?
Darcis, G., Driessche, B. V., & Lint, C. M. V. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.003 · Cited by 157
Barriers for HIV Cure: The Latent Reservoir
Castro‐Gonzalez, S., Colomer-Lluch, M., & Serra-Moreno, R. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0118 · Cited by 154
Jiang, G., & Dandekar, S. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0199 · Cited by 152
Avram, D., Fields, A. J., Senawong, T., Topark‐Ngarm, A., & Leid, M. E. (2002) · Biochemical Journal · doi:10.1042/bj20020496 · Cited by 152
Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques
Gama, L., Abreu, C. M., Shirk, E. N., Price, S. L., Li, M., Laird, G. M., Pate, K. A. M., Wietgrefe, S. W., O’Connor, S. L., Pianowski, L. F., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001267 · Cited by 152
Establishment of latent HIV-1 reservoirs: what do we really know?
Vanhamel, J., Bruggemans, A., & Debyser, Z. (2019) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30275-2 · Cited by 151
Veenstra, M., León‐Rivera, R., Li, M., Gama, L., Clements, J. E., & Berman, J. W. (2017) · mBio · doi:10.1128/mbio.01280-17 · Cited by 150
Latency: the hidden HIV-1 challenge
Marcello, A. (2006) · Retrovirology · doi:10.1186/1742-4690-3-7 · Cited by 149
Self-citationStrain, M. C., Letendre, S. L., Pillai, S. K., Russell, T., Ignacio, C. C., Günthard, H. F., Good, B. M., Smith, D. M., Wolinsky, S. M., Furtado, M. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1772-1788.2005 · Cited by 144
Screening for Cognitive Impairment in Human Immunodeficiency Virus
Valcour, V., Paul, R. H., Chiao, S., Wendelken, L. A., & Miller, B. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir524 · Cited by 143
Tavazzi, E., Morrison, D., Sullivan, P. D., Morgello, S., & Fischer, T. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526114956 · Cited by 142
The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention
Xu, H., Wang, Z., Li, J., Wu, H., Peng, Y., Fan, L., Chen, J., Gu, C., Yan, F., Wang, L., et al. (2017) · Neural Plasticity · doi:10.1155/2017/5405104 · Cited by 141
Castellano, P., Prevedel, L., & Eugenín, E. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12758-w · Cited by 141
Microglia as a Pharmacological Target in Infectious and Inflammatory Diseases of the Brain
Rock, R. B., & Peterson, P. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9012-8 · Cited by 140
Scully, E. P., & Alter, G. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0310-3 · Cited by 139
Smit, T. K., Brew, B. J., Tourtellotte, W. W., Morgello, S., Gelman, B. B., & Saksena, N. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.10133-10148.2004 · Cited by 137
Letendre, S. L., Mills, A., Tashima, K. T., Thomas, D. A., Min, S. S., Chen, S., Song, I., Piscitelli, S. C., & on behalf of the extended ING116070 study team (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu477 · Cited by 134
Zhang, Y., Shao, F., Wang, Q., Xie, X., & Wang, W. (2017) · Neural Plasticity · doi:10.1155/2017/9382797 · Cited by 130
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G. S., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 123
Self-citationBlood–brain barrier pericytes as a target for HIV-1 infection
Bertrand, L., Cho, H. J., & Toborek, M. J. (2018) · Brain · doi:10.1093/brain/awy339 · Cited by 122
CRISPR-mediated Activation of Latent HIV-1 Expression
Limsirichai, P., Gaj, T., & Schaffer, D. V. (2015) · Molecular Therapy · doi:10.1038/mt.2015.213 · Cited by 121
Is the central nervous system a reservoir of HIV-1?
Gray, L. R., Roche, M., Flynn, J. K., Wesselingh, S. L., Gorry, P. R., & Churchill, M. J. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000108 · Cited by 116
Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs
Sadowski, I., & Hashemi, F. B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03156-8 · Cited by 115
Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
Alvarez-Carbonell, D., García‐Mesa, Y., Milne, S., Das, B., Dobrowolski, C. N., Rojas, R. E., & Karn, J. (2017) · Retrovirology · doi:10.1186/s12977-017-0335-8 · Cited by 113
Targeting the Brain Reservoirs: Toward an HIV Cure
Marban, C., Forouzanfar, F., Aït-Ammar, A., Fahmi, F., Mekdad, H. E., Daouad, F., Rohr, O., & Schwartz, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00397 · Cited by 111
Self-citationCerebrospinal Fluid HIV Escape from Antiretroviral Therapy
Ferretti, F., Gisslén, M., Cinque, P. M., & Price, R. W. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0267-7 · Cited by 110
Epigenetic control of HIV-1 post integration latency: implications for therapy
Kumar, A., Darcis, G., Lint, C. M. V., & Herbein, G. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0137-6 · Cited by 108
Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS
Bednar, M. M., Sturdevant, C. B., Tompkins, L. A., Arrildt, K. T., Dukhovlinova, E., Kincer, L. P., & Swanstrom, R. I. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0265-9 · Cited by 107
Vázquez, N., Greenwell‐Wild, T., Marinos, N. J., Swaim, W. D., Nares, S., Ott, D. E., Schubert, U., Henklein, P., Orenstein, J. M., Sporn, M. B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4479-4491.2005 · Cited by 105
Off‐target effects of engineered nucleases
Yee, J. (2016) · FEBS Journal · doi:10.1111/febs.13760 · Cited by 103
Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9
Yoder, K. E., & Bundschuh, R. A. (2016) · Scientific Reports · doi:10.1038/srep29530 · Cited by 103
Campos, N., Myburgh, R., Garcel, A., Vautrin, A., Lapasset, L., Nadal, E. S., Mahuteau‐Betzer, F., Najman, R., Fornarelli, P., Tantale, K., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0159-3 · Cited by 102
Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Driessche, B. V., Corazza, F., Gatot, J., Mélard, A., Vanhulle, C., Kabeya, K., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201505557 · Cited by 101
Self-citationSalemi, M., Lamers, S. L., Yu, S. W. Y., de Oliveira, T., Fitch, W. M., & McGrath, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11343-11352.2005 · Cited by 101
A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
Mlčochová, P., Sutherland, K. A., Watters, S. A., Bertoli, C., de Bruin, R. A. M., Rehwinkel, J., Neil, S. J. D., Lenzi, G. M., Kim, B., Khwaja, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696025 · Cited by 98
CTIP2 is a negative regulator of P-TEFb
Cherrier, T., Douce, V. L., Eilebrecht, S., Riclet, R., Marban, C., Dequiedt, F., Goumon, Y., Paillart, J., Mericskay, M., Parlakian, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220136110 · Cited by 97
Self-citationCRISPR-Cas based antiviral strategies against HIV-1
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2017) · Virus Research · doi:10.1016/j.virusres.2017.07.020 · Cited by 94
LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing
Douce, V. L., Colin, L., Redel, L., Cherrier, T., Herbein, G., Aunis, D., Rohr, O., Lint, C. M. V., & Schwartz, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr857 · Cited by 92
Self-citationReactivation of latent HIV-1 by new semi-synthetic ingenol esters
José, D. P., Bartholomeeusen, K., da Cunha, R. D., Abreu, C. M., Gliński, J. A., da Costa, T. B. F., Rabay, A. F. M. B., Filho, L. F. P., Dudycz, L. W., Ranga, U., et al. (2014) · Virology · doi:10.1016/j.virol.2014.05.033 · Cited by 91
Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread
Cenker, J. J., Stultz, R. D., & McDonald, D. J. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0004 · Cited by 90
Myeloid Cell Interaction with HIV: A Complex Relationship
Rodrigues, V., Ruffin, N., Jouve, M. J., & Benaroch, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01698 · Cited by 89
Deep latency: A new insight into a functional HIV cure
Elsheikh, M. M., Tang, Y., Li, D., & Jiang, G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.020 · Cited by 85
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells
Grabarczyk, P., Przybylski, G. K., Depke, M., Völker, U., Bahr, J., Assmus, K., Bröker, B. M., Walther, R., & Schmidt, C. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210152 · Cited by 84
Are microRNAs Important Players in HIV-1 Infection? An Update
Balasubramaniam, M., Pandhare, J., & Dash, C. (2018) · Viruses · doi:10.3390/v10030110 · Cited by 84
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
Badía, R., Ballana, E., Castellví, M., García-Vidal, E., Pujantell, M., Clotet, B., Prado, J. G., Puig, J., Martínez, M. Á., Riveira‐Muñoz, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05157-w · Cited by 84
Rohr, O., Lecestre, D., Chasserot‐Golaz, S., Marban, C., Avram, D., Aunis, D., Leid, M. E., & Schaeffer, E. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5415-5427.2003 · Cited by 82
Self-citationHaddow, L. J., Floyd, S., Copas, A. J., & Gilson, R. J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061826 · Cited by 82
Humanized Mouse Models for Human Immunodeficiency Virus Infection
Marsden, M. D., & Zack, J. A. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041703 · Cited by 82
Barber, S. A., Gama, L., Dudaronek, J. M., Voelker, T., Tarwater, P. M., & Clements, J. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/500983 · Cited by 80
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Gisslén, M., Heslegrave, A., Veleva, E., Yilmaz, A., Andersson, L., Hagberg, L., Spudich, S., Fuchs, D., Price, R. W., & Zetterberg, H. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000512 · Cited by 79
Mathews, S., Woods, A. B., Katano, I., Makarov, E., Thomas, M. B., Gendelman, H. E., Poluektova, L. Y., Ito, M., & Gorantla, S. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0311-y · Cited by 79
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
Halper-Stromberg, A., & Nussenzweig, M. C. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80561 · Cited by 78
Histone H3 Lysine 4 di-methylation: A novel mark for transcriptional fidelity?
Pinskaya, M., & Morillon, A. (2009) · Epigenetics · doi:10.4161/epi.4.5.9369 · Cited by 77
Abassi, M., Morawski, B. M., Nakigozi, G. F., Nakasujja, N., Kong, X., Meya, D. B., Robertson, K., Gray, R. H., Wawer, M. J., Sacktor, N. C., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0505-9 · Cited by 76
Sung, T.-L., & Rice, A. P. (2006) · Retrovirology · doi:10.1186/1742-4690-3-66 · Cited by 74
Gliotransmitters and cytokines in the control of blood-brain barrier permeability
Osipova, E. D., Semyachkina-Glushkovskaya, O. V., Morgun, A. V., Pisareva, N. V., Malinovskaya, N. A., Boitsova, E. B., Pozhilenkova, E. A., Belova, O. A., Salmin, V. V., Taranushenko, T. E., et al. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0092 · Cited by 72
Asahchop, E. L., Méziane, O., Mamik, M. K., Chan, W. F., Branton, W. G., Resch, L., Gill, M. J., Haddad, É., Guimond, J. V., Wainberg, M. A., et al. (2017) · Retrovirology · doi:10.1186/s12977-017-0370-5 · Cited by 71
Edén, A., Nilsson, S., Hagberg, L., Fuchs, D., Zetterberg, H., Svennerholm, B., & Gisslén, M. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw454 · Cited by 70
Drug targeting strategies into the brain for treating neurological diseases
Barnabas, W. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.10.015 · Cited by 70
HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFκB signaling axis
Periyasamy, P., Thangaraj, A., Bendi, V. S., & Buch, S. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.011 · Cited by 70
CRISPR/Cas9: a double-edged sword when used to combat HIV infection
Chen, L., Wainberg, M. A., Das, A. T., & Berkhout, B. (2016) · Retrovirology · doi:10.1186/s12977-016-0270-0 · Cited by 67
Periyasamy, P., Thangaraj, A., Guo, M., Hu, G., Callen, S. E., & Buch, S. J. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3474-17.2018 · Cited by 66
Schwartz, C., Catez, P., Rohr, O., Lecestre, D., Aunis, D., & Schaeffer, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.65-73.2000 · Cited by 65
Self-citationHMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters
Eilebrecht, S., Douce, V. L., Riclet, R., Targat, B., Hallay, H., Driessche, B. V., Schwartz, C., Robette, G., Lint, C. M. V., Rohr, O., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku168 · Cited by 62
Self-citationThe Molecular Biology of HIV Latency
Khoury, G., Darcis, G., Lee, M. Y.-H., Bouchat, S., Driessche, B. V., Purcell, D. F. J., & Lint, C. M. V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_8 · Cited by 61
Woods, S. P., Morgan, E. E., Marquie‐Beck, J., Carey, C. L., Grant, I., & Letendre, S. L. (2006) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000213916.10514.57 · Cited by 58
Venneti, S., Lopresti, B. J., Wang, G., Bissel, S. J., Mathis, C. A., MELTZER, C. C., Boada, F. E., Capuano, S., Kress, G. J., Davis, D. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20227 · Cited by 57
Stochastic Fate Selection in HIV-Infected Patients
Weinberger, A. D., & Weinberger, L. S. (2013) · Cell · doi:10.1016/j.cell.2013.09.039 · Cited by 56
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection
Ferrari, G., Haynes, B. F., Koenig, S., Nordstrom, J. L., Margolis, D. M., & Tomaras, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.173 · Cited by 56
Sheng, Z., Liu, Y., Li, H., Zheng, W., Xia, B., Zhang, X., Yong, V. W., & Xue, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01103 · Cited by 56
Llewellyn, G. N., Alvarez-Carbonell, D., Chateau, M., Karn, J., & Cannon, P. M. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0604-2 · Cited by 55
Ginsberg, S. D., Alldred, M. J., Gunnam, S. M., Schiroli, C., Lee, S. H., Morgello, S., & Fischer, T. (2018) · Annals of Neurology · doi:10.1002/ana.25160 · Cited by 52
PKC phosphorylates HEXIM1 and regulates P-TEFb activity
Fujinaga, K., Barborič, M., Li, Q., Luo, Z., Price, D. H., & Peterlin, B. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks682 · Cited by 51
Development and characterization of a human microglia cell model of HIV-1 infection
Rawat, P., & Spector, S. A. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0472-1 · Cited by 51
On the way to find a cure: Purging latent HIV-1 reservoirs
Schwartz, C., Bouchat, S., Marban, C., Gautier, V., Lint, C. M. V., Rohr, O., & Douce, V. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.001 · Cited by 50
Self-citationDevelopment of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting
Vaz, G. R., Hädrich, G., Bidone, J., Rodrigues, J. L., Falkembach, M., Putaux, J., Hort, M. A., Monserrat, J. M., Varela, A. S., Teixeira, H. F., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160355 · Cited by 50
Churchill, M. J., Cowley, D., Wesselingh, S. L., Gorry, P. R., & Gray, L. R. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0271-5 · Cited by 48
Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages
Kamimura, K., Mishima, Y., Obata, M., Endo, T., Aoyagi, Y., & Kominami, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210388 · Cited by 47
Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells
Hansen, E. C., Ransom, M., Hesselberth, J. R., Hosmane, N. N., Capoferri, A. A., Bruner, K. M., Pollack, R. A., Zhang, H., Drummond, M., Siliciano, J. D., et al. (2016) · eLife · doi:10.7554/elife.18447 · Cited by 45
Chen, G., Liu, S., Pan, R., Li, G., Tang, H., Jiang, M., Xing, Y., Jin, F., Lin, L., & Dong, J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0616-3 · Cited by 45
Salemi, M., & Rife, B. (2016) · Current HIV Research · doi:10.2174/1570162x13666151029102413 · Cited by 44
Gray, L. R., Cowley, D., Welsh, C., Lu, H. K., Brew, B. J., Lewin, S. R., Wesselingh, S. L., Gorry, P. R., & Churchill, M. J. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.111 · Cited by 43
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
Richard, K., Williams, D. E., de Silva, E. D., Brockman, M. A., Brumme, Z. L., Andersen, R. J., & Tietjen, I. (2018) · Viruses · doi:10.3390/v10070348 · Cited by 43
GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
Zhu, L. J., Lawrence, M., Gupta, A., Pagès, H., Küçükural, A., Garber, M. G., & Wolfe, S. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3746-y · Cited by 42
Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium
Al-Harti, L., Joseph, J., & Nath, A. (2018) · Journal of NeuroVirology · doi:10.1007/s13365-018-0691-8 · Cited by 42
Sarracino, A., Gharu, L., Kula, A., Pasternak, A. O., Avettand-Fènoël, V., Rouzioux, C., Bardina, M. V., Wit, S. D., Benkirane, M., Berkhout, B., et al. (2018) · mBio · doi:10.1128/mbio.02158-18 · Cited by 42
Self-citationHIV Eradication Strategies: Implications for the Central Nervous System
Veenhuis, R. T., Clements, J. E., & Gama, L. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00428-7 · Cited by 42
The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells
Alvarez-Carbonell, D., Ye, F., Ramanath, N., Dobrowolski, C. N., & Karn, J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9798-1 · Cited by 41
Retroviral E-DNA: persistence and gene expression in nondividing immune cells
Cara, A., & Klotman, M. E. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306151 · Cited by 40
T-cell therapies for HIV: Preclinical successes and current clinical strategies
Patel, S., Jones, R. B., Nixon, D. F., & Bollard, C. M. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.04.007 · Cited by 40
Role of T Lymphocytes in HIV Neuropathogenesis
Subra, C., & Trautmann, L. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00445-6 · Cited by 40
HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing
Forouzanfar, F., Ali, S., Wallet, C., Rovere, M. D., Ducloy, C., Mekdad, H. E., Maassarani, M. E., Aït-Ammar, A., Assche, J. V., Boutant, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48689-x · Cited by 40
Self-citationHIV Persistence on Antiretroviral Therapy and Barriers to a Cure
Sung, J., & Margolis, D. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0484-2_7 · Cited by 38
CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
Panfil, A. R., London, J. A., Green, P. L., & Yoder, K. E. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03107 · Cited by 36
HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3)
Santerre, M., Bagashev, A., Gorecki, L., Lysek, K. Z., Wang, Y., Shrestha, J., Carpio‐Cano, F. D., Mukerjee, R., & Sawaya, B. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003744 · Cited by 33
Peering into the HIV reservoir
García, M., Buzón, M. J., Benito, J. M., & Rallón, N. I. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1981 · Cited by 32
Targeting the latent reservoir to achieve functional HIV cure
Cary, D. C., & Peterlin, B. M. (2016) · F1000Research · doi:10.12688/f1000research.8109.1 · Cited by 31
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
Darcis, G., Das, A. T., & Berkhout, B. (2018) · Viruses · doi:10.3390/v10040157 · Cited by 31
Gupta, S. K., Kesarla, R., & Omri, A. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1583206 · Cited by 31
HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1
Douce, V. L., Forouzanfar, F., Eilebrecht, S., Driessche, B. V., Aït-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., et al. (2016) · Scientific Reports · doi:10.1038/srep34920 · Cited by 30
Self-citationMacrophage-Microglia Networks Drive M1 Microglia Polarization After Mycobacterium Infection
Qin, Y., Sun, X., Shao, X., Cheng, C., Feng, J., Sun, W., Gu, D., Liu, W., Xu, F., & Duan, Y. (2015) · Inflammation · doi:10.1007/s10753-015-0136-y · Cited by 29
The Many Lives of CTIP2: From AIDS to Cancer and Cardiac Hypertrophy
Douce, V. L., Cherrier, T., Riclet, R., Rohr, O., & Schwartz, C. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24490 · Cited by 29
Self-citationSu, H., Cheng, Y., Sravanam, S., Mathews, S., Gorantla, S., Poluektova, L. Y., Dash, P. K., & Gendelman, H. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00340 · Cited by 29
Kill: boosting HIV-specific immune responses
Trautmann, L. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000286 · Cited by 28
SIV Latency in Macrophages in the CNS
Gama, L., Abreu, C. M., Shirk, E. N., Queen, S. E., Beck, S. E., Pate, K. A. M., Bullock, B. T., Zink, M. C., Mankowski, J. L., & Clements, J. E. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_89 · Cited by 27
Probabilistic control of HIV latency and transactivation by the Tat gene circuit
Cao, Y., Lei, X., Ribeiro, R. M., Perelson, A. S., & Liang, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811195115 · Cited by 27
Buhrman, J. D., Jordan, K. R., Munson, D. J., Moore, B. L., Kappler, J. W., & Slansky, J. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509554 · Cited by 26
Cyclin-dependent kinases as therapeutic targets for HIV-1 infection
Rice, A. P. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254619 · Cited by 25
HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription
Eilebrecht, S., Wilhelm, E., Benecke, B., Bell, B., & Benecke, A. (2013) · RNA Biology · doi:10.4161/rna.23686 · Cited by 24
Sinharay, S., & Hammoud, D. A. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00419-8 · Cited by 24
Cited by
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Rohr, O., & Van Lint, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03060 · Cited by 163
Self-citationHIV TAT-mediated microglial senescence: Role of SIRT3-dependent mitochondrial oxidative stress
Thangaraj, A., Chivero, E. T., Tripathi, A., Singh, S., Niu, F., Guo, M.-L., Pillai, P., Periyasamy, P., & Buch, S. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101843 · Cited by 76
Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids
Gumbs, S. B. H., Berdenis van Berlekom, A., Kübler, R., Schipper, P. J., Gharu, L., Boks, M. P., Ormel, P. R., Wensing, A. M. J., de Witte, L. D., & Nijhuis, M. (2022) · Viruses · doi:10.3390/v14040829 · Cited by 65
miR-142-3p Regulates BDNF Expression in Activated Rodent Microglia Through Its Target CAMK2A
Gupta, N., Jadhav, S., Tan, K.-L., Saw, G., Mallilankaraman, K. B., & Dheen, S. T. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00132 · Cited by 40
Metadata
- Authors
- Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., & Schwartz, C.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-10-24
- Volume
- 9
- Pages
- 362-362
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2981577557
- Cited by
- 368
- References
- 211
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.